Search - Centre François Baclesse Access content directly

Filter your results

103 Results
Deposit type : Notice

Etude de phase II sur l’efficacité et la tolérance d’une augmentation de dose de radiothérapie des lésions hypoxiques définies par TEP-scanographie au fluoromisonidazole chez les patients suivis pour un cancer bronchique non à petites cellules

Sébastien Thureau , Philippe Chaumet Riffaud , Romain Modzelewski , Sébastien Hapdey , Marc Mahé , et al.
Congrès de la Société Française de Radiothérapie et Oncologie, 2016, Paris, France
Conference poster hal-01665300v1

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Preexisting Autoimmune Disease: A Nationwide Multicenter Cohort Study

Alice Tison , Gilles Quéré , Laurent Misery , Elisa Funck-Brentano , François Danlos , et al.
Arthritis & rheumatology, 2019, ⟨10.1002/art.41068⟩
Journal articles hal-02267195v1

A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nicolas Penel , Olivier Mir , Jennifer Wallet , Isabelle Ray-Coquard , Axel Le Cesne , et al.
European Journal of Cancer, 2020, 126, pp.45-55. ⟨10.1016/j.ejca.2019.12.001⟩
Journal articles hal-03623680v1

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

P. Rodon , C. Hulin , B. Pegourie , M. Tiab , B. Anglaret , et al.
Haematologica, 2015, 100 (2), pp.e56-9. ⟨10.3324/haematol.2014.110890⟩
Journal articles hal-01116536v1

Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA

Lining Wang , Emmanuel Raffoux , Xavier Thomas , Ibrahim Yakoub-Agha , Jean-Henri Bouhris , et al.
Leukemia Research, 2017, 54, pp.12-16. ⟨10.1016/j.leukres.2017.01.002⟩
Journal articles hal-01557470v1

Impact of new generation hormono-therapy on cognitive functions in elderly patients treated for a metastatic prostate cancer

Florence Joly , Marie Lange , Natacha Heutte , Alexandra Leconte , Isabelle Léger , et al.
ASCO annual meeting, Jun 2016, Chicago, United States
Conference poster hal-02345997v1

Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013

Anne Ducassou , Laetitia Padovani , Leonor L. Chaltiel , Stéphanie Bolle , Jean-Louis Habrand , et al.
International Journal of Radiation Oncology, Biology, Physics, 2018, 102 (1), pp.166-173. ⟨10.1016/j.ijrobp.2018.05.036⟩
Journal articles hal-02478966v1

Role of the internet as an information resource before anaesthesia consultation

Bastian Nucci , Pierre-Géraud Claret , Gilles Leclerc , Arnaud Chaumeron , Philippe Grillo , et al.
European Journal of Anaesthesiology, 2017, 34 (12), pp.831 - 835. ⟨10.1097/EJA.0000000000000686⟩
Journal articles hal-01801239v1

Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations

Pascal Pujol , Pierre Vande Perre , Laurence Faivre , Damien Sanlaville , Carole Corsini , et al.
European Journal of Human Genetics, 2018, 26 (12), pp.1732-1742. ⟨10.1038/s41431-018-0224-1⟩
Journal articles hal-01870352v1

Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing

Dede Sika Kossi , Rajae Touzani , Isabelle Borget , Zhaomin Zou , Dominique Vaur , et al.
ISPOR 19th Annual European Congress, Oct 2016, Vienne, Austria. pp.A693
Conference papers halshs-01446644v1

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer

C. Bascoul-Mollevi , S. Gourgou , M.-P. Galais , J.-L. Raoul , O. Bouche , et al.
European Journal of Cancer, 2017, 84, pp.239 - 249. ⟨10.1016/j.ejca.2017.07.038⟩
Journal articles hal-01688845v1

Radiotherapy of T4M0 prostate cancer : A multicentric retrospective analysis

F. Goupy , E. Meyer , P. Pommier , N. Magne , P. Sargos , et al.
Radiotherapy & Oncology, 2020, 152, pp.S59-S59
Journal articles hal-03284472v1

Localized Myxofibrosarcomas: Roles of Surgical Margins and Adjuvant Radiation Therapy

Raoudha Boughzala-Bennadji , Eberhard Stoeckle , Cécile Le Péchoux , Pierre Méeus , Charles Honoré , et al.
International Journal of Radiation Oncology, Biology, Physics, 2018, 102 (2), pp.399-406. ⟨10.1016/j.ijrobp.2018.05.055⟩
Journal articles hal-02049039v1

[COVID-19 and People Followed for Breast Cancer: French Guidelines for Clinical Practice of Nice-St Paul De Vence, in Collaboration With the Collège Nationale Des Gynécologues Et Obstétriciens Français (CNGOF), the Société d'Imagerie De La Femme (SIFEM), the Société Française De Chirurgie Oncologique (SFCO), the Société Française De Sénologie Et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]

Joseph Gligorov , Thomas Bachelot , Jean-Yves Pierga , Eric-Charles Antoine , Corinne Balleyguier , et al.
Bulletin du Cancer, 2020, 107 (5), pp.528-537. ⟨10.1016/j.bulcan.2020.03.008⟩
Journal articles hal-02869600v1

Clinical Benefit of Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma: The French Retrospective SECTOR Study

Stéphane Oudard , Florence Joly , Lionnel Geoffrois , Brigitte Laguerre , Nadine Houédé , et al.
Clinical Genitourinary Cancer, 2016, 14 (6), pp.e595 - e607. ⟨10.1016/j.clgc.2016.04.019⟩
Journal articles hal-01904931v1

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

Thierry André , Dewi Vernerey , Laurent Mineur , Jaafar Bennouna , Jérôme Desramé , et al.
Journal of Clinical Oncology, 2018, 36 (15), pp.1469-1477. ⟨10.1200/JCO.2017.76.0355⟩
Journal articles hal-01951156v1

Prospective Evaluation of the Impact of Antiangiogenic Treatment on Cognitive Functions in Metastatic Renal Cancer

Florence Joly , Natacha Heutte , Brigitte Duclos , Sabine Noal , Isabelle Léger-Hardy , et al.
European Urology Focus, 2016, 2 (6), pp.642 - 649. ⟨10.1016/j.euf.2016.04.009⟩
Journal articles hal-01893539v1

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study

Emeline Tabouret , François Bertucci , Jean-Yves Pierga , Thierry Petit , Christelle Levy , et al.
Oncotarget, 2016, 7 (14), pp.18531-18540. ⟨10.18632/oncotarget.7612⟩
Journal articles hal-03623733v1

Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies

Dimitri Carene , Alicia Tran-Dien , Jérôme Lemonnier , Florence Dalenc , Christelle Levy , et al.
Breast Cancer Research and Treatment, 2020, 179 (2), pp.387-401. ⟨10.1007/s10549-019-05462-y⟩
Journal articles hal-03769556v1

Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis

Elvire Pons-Tostivint , Youlia Kirova , Amélie Lusque , Mario Campone , Julien Geffrelot , et al.
Radiotherapy & Oncology, 2020, 145, pp.109-116. ⟨10.1016/j.radonc.2019.12.019⟩
Journal articles hal-02888440v1

Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France

A. Auperin , R. Obongo , F.R. Ferrand , N. Saroul , F. Janot , et al.
European Journal of Cancer, 2019, 123, pp.1-10. ⟨10.1016/j.ejca.2019.09.007⟩
Journal articles hal-02548630v1

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases

William Jacot , Elvire Pons , Jean-Sébastien Frenel , Séverine Guiu , Christelle Levy , et al.
Breast Cancer Research and Treatment, 2016, 157 (2), pp.307-318. ⟨10.1007/s10549-016-3828-6⟩
Journal articles hal-02296735v1

Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers

Lisa Golmard , Laurent Castéra , Sophie Krieger , Virginie Moncoutier , Khadija Abidallah , et al.
European Journal of Human Genetics, 2017, 25 (12), pp.1345-1353. ⟨10.1038/s41431-017-0021-2⟩
Journal articles hal-02194429v1

Parental disclosure of positive BRCA1/2 mutation status to children 10 years after genetic testing

Jaïs Troian , Thémis Apostolidis , Rajae Touzani , Emmanuelle Mouret-Fourme , Dominique Stoppa-Lyonnet , et al.
Psychology, Health and Medicine, 2020, pp.1-11. ⟨10.1080/13548506.2019.1659981⟩
Journal articles hal-02541592v1

Adolescent and young adult oncology patients in France Heterogeneity in pathways of care

Emmanuel Desandes , Laurence Brugières , Florence Molinié , Gautier Defossez , Patricia Delafosse , et al.
Pediatric Blood and Cancer, 2018, 65 (9), pp.e27235. ⟨10.1002/pbc.27235⟩
Journal articles hal-02194316v1

Metastatic Renal Cell Carcinoma Rapidly Progressive to Sunitinib: What to Do Next?

Melissa Bersanelli , Roberto Iacovelli , Sebastiano Buti , Nadine Houédé , Brigitte Laguerre , et al.
European Urology Oncology, 2019, ⟨10.1016/j.euo.2019.06.018⟩
Journal articles hal-02930883v1

Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial

Martin Schlumberger , Sophie Leboulleux , Bogdan Catargi , Désirée Deandreis , Slimane Zerdoud , et al.
The Lancet. Diabetes & Endocrinology , 2018, 6 (8), pp.618-626
Journal articles hal-02052247v1

Implication du pharmacien dans l’accompagnement des patients sous anticancéreux oraux : état des lieux dans les centres de lutte contre le cancer (CLCC)

Sandrine Occhipinti , Emilie Petit-Jean , Frédéric Pinguet , Cécile Beaupin , Mikaël Daouphars , et al.
Bulletin du Cancer, 2017, 104 (9), pp.727-734. ⟨10.1016/j.bulcan.2017.06.012⟩
Journal articles hal-02361152v1

Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab

Benoit Dupont , Delphine Mariotte , Audrey E. Dugue , Benedicte Clarisse , Jean-Michel Grellard , et al.
British Journal of Clinical Pharmacology, 2017, 83 (3), pp.623-631. ⟨10.1111/bcp.13140⟩
Journal articles hal-03598678v1

Impact of the NTCP modeling on medical decision to select eligible patient for proton therapy: the usefulness of EUD as an indicator to rank modern photon vs proton treatment plans

Abdulhamid Chaikh , Valentin Calugaru , Pierre-Yves Bondiau , Juliette Thariat , Jacques Balosso
International Journal of Radiation Biology, 2018, pp.1 - 26. ⟨10.1080/09553002.2018.1486516⟩
Journal articles in2p3-01834894v1